METASTATIC NEUROENDOCRINE NEOPLASM
Clinical trials for METASTATIC NEUROENDOCRINE NEOPLASM explained in plain language.
Never miss a new study
Get alerted when new METASTATIC NEUROENDOCRINE NEOPLASM trials appear
Sign up with your email to follow new studies for METASTATIC NEUROENDOCRINE NEOPLASM, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Heart-Saving hope for rare cancer patients in major trial
Disease control OngoingThis study is testing if adding a drug called telotristat ethyl to standard hormone therapy better protects the heart in patients with advanced neuroendocrine tumors. About 80 patients will be randomly assigned to receive either the new drug combination or a placebo with standard…
Matched conditions: METASTATIC NEUROENDOCRINE NEOPLASM
Phase: PHASE3 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC
-
New Triple-Threat attack on aggressive neuroendocrine cancers
Disease control OngoingThis study is testing whether a combination of three drugs can help control advanced, aggressive neuroendocrine cancers that have worsened after one prior treatment. The drugs work together: one aims to block tumor growth directly, while the other two aim to help the patient's ow…
Matched conditions: METASTATIC NEUROENDOCRINE NEOPLASM
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 20, 2026 14:47 UTC